Carisma Therapeutics Reports Fiscal 2022 Financial Results and Recent Business Highlights
Closed merger with Sesen Bio and commenced trading on Nasdaq under ticker symbol CARM Cash position as of the closing of the merger with Sesen Bio provides anticipated operating runway through... | April 4, 2023